Nifty

:

25461.30

Sensex

:

83442.50

0.30 (0.00%)
9.61 (0.01%)

Login

Nifty
Sensex

:
:

25461.30
83442.50

0.30 (0.00%)
9.61 (0.01%)

FDC Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

65/99

BSE: 531599 | NSE: FDC

Watchlist

NSE BSE

489.40

04-Jul-2025

Open
High
Low
Previous Close

488.75
492.2
485.25
487.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

87185
42583560.9
658.85
366.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,965.48
29.86
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,912.82
N/A
3.49

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.13
7.65
8.34

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.48
2.94
5.94

PAT CAGR (%)

10 Years
5 Years
3 Years

7.50
4.85
12.15

P:E (Median)

8 Years
5 Years
3 Years

21.23
24.32
25.95

P:BV (Average)

8 Years
5 Years
3 Years

2.91
3.01
3.04

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.26
15.34
17.07

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 18.58 16.39
P/E Ratio 26.34 29.86
Revenue 1935 2108
EBITDA 339
Net Income 305 267
ROA 12.7
P/B Ratio 3.80
ROE 14.96
FCFF 155
FCFF Yield 2.22
Net Debt -455
BVPS 128.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 482.00 454.23 6.11% 458.86 452.21 1.47% 505.10 479.70 5.29% 624.14 530.04 17.75%
Expenses 429.18 396.39 8.27% 412.92 370.31 11.51% 432.70 400.99 7.91% 482.45 410.03 17.66%
EBITDA 52.83 57.84 -8.66% 45.94 81.90 -43.91% 72.40 78.71 -8.02% 141.69 120.01 18.07%
EBIDTM 10.96% 12.73% 10.01% 18.11% 14.33% 16.41% 22.70% 22.64%
Other Income 31.43 20.72 51.69% 18.64 25.33 -26.41% 34.68 27.39 26.62% 28.15 29.78 -5.47%
Interest 1.18 0.94 25.53% 0.94 0.97 -3.09% 1.07 1.05 1.90% 1.29 1.04 24.04%
Depreciation 15.53 10.39 49.47% 13.32 9.93 34.14% 13.76 9.81 40.27% 11.00 9.59 14.70%
PBT 67.54 67.22 0.48% 50.32 96.33 -47.76% 92.25 95.23 -3.13% 157.56 139.16 13.22%
Tax 19.33 19.02 1.63% 13.87 17.96 -22.77% 18.28 23.19 -21.17% 42.57 30.61 39.07%
PAT 48.21 48.20 0.02% 36.45 78.38 -53.50% 73.97 72.04 2.68% 114.99 108.55 5.93%
PATM 10.00% 10.61% 7.94% 17.33% 14.65% 15.02% 18.42% 20.48%
EPS 2.96 2.96 0.00% 2.24 4.81 -53.43% 4.54 4.43 2.48% 7.06 6.67 5.85%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 491.89 462.03 6.46% 464.11 458.17 1.30% 513.85 486.37 5.65% 638.27 536.38 19.00%
Expenses 437.91 405.71 7.94% 417.46 374.38 11.51% 443.69 409.94 8.23% 491.65 414.37 18.65%
EBITDA 53.98 56.33 -4.17% 46.65 83.79 -44.33% 70.16 76.42 -8.19% 146.62 122.00 20.18%
EBIDTM 10.97% 12.19% 10.05% 18.29% 13.65% 15.71% 22.97% 22.75%
Other Income 16.08 20.27 -20.67% 18.83 24.71 -23.80% 34.70 27.24 27.39% 28.44 29.42 -3.33%
Interest 1.19 0.95 25.26% 0.95 0.97 -2.06% 1.07 1.06 0.94% 1.30 1.05 23.81%
Depreciation 15.56 10.44 49.04% 13.36 9.97 34.00% 13.79 9.87 39.72% 11.02 9.63 14.43%
PBT 53.31 65.21 -18.25% 51.18 97.55 -47.53% 90.00 92.73 -2.94% 162.73 140.74 15.62%
Tax 14.64 18.93 -22.66% 14.14 18.37 -23.03% 17.96 22.94 -21.71% 43.70 30.93 41.29%
PAT 38.67 46.28 -16.44% 37.04 79.17 -53.21% 72.04 69.79 3.22% 119.04 109.81 8.41%
PATM 7.86% 10.02% 7.98% 17.28% 14.02% 14.35% 18.65% 20.47%
EPS 2.38 2.84 -16.20% 2.27 4.87 -53.39% 4.42 4.29 3.03% 7.31 6.62 10.42%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,070.10 1,916.19 1,777.03 1,518.97 1,325.45 1,331.09 1,075.87 1,062.20 1,008.91 986.81 877.65 Net Sales Growth 8.03% 7.83% 16.99% 14.60% -0.42% 23.72% 1.29% 5.28% 2.24% 12.44% Cost Of Goods Sold 724.38 645.81 654.26 527.84 412.05 424.53 344.49 349.98 338.09 355.07 266.17 Gross Profit 1,345.72 1,270.37 1,122.77 991.12 913.40 906.56 731.39 712.22 670.81 631.74 611.48 GP Margin 65.01% 66.30% 63.18% 65.25% 68.91% 68.11% 67.98% 67.05% 66.49% 64.02% 69.67% Total Expenditure 1,757.25 1,577.73 1,523.84 1,272.12 1,001.12 1,047.51 855.83 843.10 766.96 759.85 680.92 Power & Fuel Cost - 37.38 34.08 28.89 27.06 27.38 24.60 21.98 21.52 23.12 20.15 % Of Sales - 1.95% 1.92% 1.90% 2.04% 2.06% 2.29% 2.07% 2.13% 2.34% 2.30% Employee Cost - 408.99 386.99 339.97 294.31 276.18 226.19 215.47 189.93 174.53 136.24 % Of Sales - 21.34% 21.78% 22.38% 22.20% 20.75% 21.02% 20.29% 18.83% 17.69% 15.52% Manufacturing Exp. - 170.27 154.77 128.20 77.94 68.76 62.19 58.70 49.34 36.39 97.19 % Of Sales - 8.89% 8.71% 8.44% 5.88% 5.17% 5.78% 5.53% 4.89% 3.69% 11.07% General & Admin Exp. - 103.67 99.60 69.39 54.95 57.18 58.56 60.53 52.70 49.55 41.11 % Of Sales - 5.41% 5.60% 4.57% 4.15% 4.30% 5.44% 5.70% 5.22% 5.02% 4.68% Selling & Distn. Exp. - 181.93 168.58 147.47 87.68 94.70 78.94 75.96 64.36 57.73 64.96 % Of Sales - 9.49% 9.49% 9.71% 6.62% 7.11% 7.34% 7.15% 6.38% 5.85% 7.40% Miscellaneous Exp. - 29.68 25.56 30.36 47.13 98.78 60.87 60.47 50.99 63.47 64.96 % Of Sales - 1.55% 1.44% 2.00% 3.56% 7.42% 5.66% 5.69% 5.05% 6.43% 6.28% EBITDA 312.86 338.46 253.19 246.85 324.33 283.58 220.04 219.10 241.95 226.96 196.73 EBITDA Margin 15.11% 17.66% 14.25% 16.25% 24.47% 21.30% 20.45% 20.63% 23.98% 23.00% 22.42% Other Income 112.90 103.22 55.29 78.73 97.15 82.66 54.80 51.25 49.65 39.98 44.38 Interest 4.48 4.00 4.04 3.05 3.40 3.41 1.43 1.40 1.41 1.40 1.75 Depreciation 53.61 39.73 38.76 37.08 37.62 37.36 33.14 35.04 34.52 33.61 38.50 PBT 367.67 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 200.85 Tax 94.05 90.78 64.72 65.82 85.96 78.68 64.76 65.59 62.72 63.03 54.94 Tax Rate 25.58% 22.81% 24.36% 23.06% 22.59% 24.18% 27.41% 28.04% 25.11% 27.18% 27.35% PAT 273.62 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 145.91 PAT before Minority Interest 273.62 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 145.91 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.22% 16.03% 11.31% 14.46% 22.22% 18.54% 15.94% 15.85% 18.54% 17.12% 16.63% PAT Growth -10.92% 52.84% -8.50% -25.42% 19.33% 43.86% 1.92% -10.03% 10.76% 15.76% EPS 16.81 18.87 12.34 13.49 18.09 15.16 10.54 10.34 11.49 10.37 8.96

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,108.12 1,942.94 1,783.75 1,527.92 1,333.20 1,344.19 1,090.70 1,075.07 1,013.87 994.32 889.31 Net Sales Growth 8.50% 8.92% 16.74% 14.61% -0.82% 23.24% 1.45% 6.04% 1.97% 11.81% Cost Of Goods Sold 736.28 656.15 655.79 530.21 414.07 425.72 345.14 352.08 339.05 357.93 272.91 Gross Profit 1,371.84 1,286.79 1,127.96 997.71 919.14 918.46 745.56 722.99 674.81 636.38 616.40 GP Margin 65.07% 66.23% 63.24% 65.30% 68.94% 68.33% 68.36% 67.25% 66.56% 64.00% 69.31% Total Expenditure 1,790.71 1,604.41 1,534.16 1,274.23 999.15 1,051.25 859.68 848.38 770.40 765.58 690.76 Power & Fuel Cost - 37.38 34.12 28.91 27.08 27.40 24.61 22.00 21.55 23.14 20.18 % Of Sales - 1.92% 1.91% 1.89% 2.03% 2.04% 2.26% 2.05% 2.13% 2.33% 2.27% Employee Cost - 413.40 390.90 343.33 296.29 277.48 225.57 216.67 191.08 175.76 137.58 % Of Sales - 21.28% 21.91% 22.47% 22.22% 20.64% 20.68% 20.15% 18.85% 17.68% 15.47% Manufacturing Exp. - 171.89 154.81 128.24 77.97 68.80 62.25 58.77 49.40 36.44 97.27 % Of Sales - 8.85% 8.68% 8.39% 5.85% 5.12% 5.71% 5.47% 4.87% 3.66% 10.94% General & Admin Exp. - 107.33 101.01 70.29 55.64 58.06 59.45 61.55 53.35 49.97 41.43 % Of Sales - 5.52% 5.66% 4.60% 4.17% 4.32% 5.45% 5.73% 5.26% 5.03% 4.66% Selling & Distn. Exp. - 187.19 171.01 147.96 87.74 94.70 78.92 75.96 64.36 57.73 64.96 % Of Sales - 9.63% 9.59% 9.68% 6.58% 7.05% 7.24% 7.07% 6.35% 5.81% 7.30% Miscellaneous Exp. - 31.06 26.53 25.28 40.37 99.07 63.73 61.35 51.61 64.61 64.96 % Of Sales - 1.60% 1.49% 1.65% 3.03% 7.37% 5.84% 5.71% 5.09% 6.50% 6.35% EBITDA 317.41 338.53 249.59 253.69 334.05 292.94 231.02 226.69 243.47 228.74 198.55 EBITDA Margin 15.06% 17.42% 13.99% 16.60% 25.06% 21.79% 21.18% 21.09% 24.01% 23.00% 22.33% Other Income 98.05 101.63 51.24 76.09 97.03 68.90 43.47 50.96 50.22 39.00 45.72 Interest 4.51 4.03 4.09 3.09 3.43 3.42 1.44 1.40 1.41 1.40 1.81 Depreciation 53.73 39.92 38.94 37.30 37.81 37.46 33.24 35.14 34.62 33.73 38.81 PBT 357.22 396.22 257.80 289.39 389.83 320.97 239.80 241.11 257.65 232.62 203.65 Tax 90.44 91.16 63.98 73.23 86.53 80.08 66.85 67.12 63.30 63.48 55.51 Tax Rate 25.32% 23.01% 24.82% 25.30% 22.32% 24.95% 28.01% 27.84% 25.14% 27.29% 27.26% PAT 266.79 305.22 194.04 216.40 301.33 240.89 171.85 173.99 188.47 169.14 148.15 PAT before Minority Interest 266.79 305.06 193.83 216.16 301.18 240.89 171.85 173.99 188.47 169.14 148.15 Minority Interest 0.00 0.16 0.21 0.24 0.15 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.66% 15.71% 10.88% 14.16% 22.60% 17.92% 15.76% 16.18% 18.59% 17.01% 16.66% PAT Growth -12.54% 57.30% -10.33% -28.19% 25.09% 40.17% -1.23% -7.68% 11.43% 14.17% EPS 16.39 18.75 11.92 13.29 18.51 14.80 10.56 10.69 11.58 10.39 9.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,097.20 1,980.74 1,948.69 1,722.17 1,541.82 1,433.04 1,262.40 1,263.72 1,076.53 929.59 Share Capital 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 17.86 Total Reserves 2,080.92 1,964.15 1,931.80 1,705.28 1,524.72 1,415.52 1,244.88 1,245.86 1,058.67 911.72 Non-Current Liabilities 597.62 462.65 384.43 299.56 314.62 229.17 211.41 216.67 19.93 24.24 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.03 0.11 0.21 0.34 0.49 0.60 0.69 0.79 0.90 Long Term Provisions 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 0.56 Current Liabilities 612.23 728.67 688.60 620.07 562.37 494.21 476.08 387.41 162.11 185.73 Trade Payables 184.63 178.48 136.26 76.66 117.54 77.20 96.95 74.66 82.30 86.26 Other Current Liabilities 99.96 95.93 85.87 76.83 79.53 60.88 66.76 63.10 49.58 36.28 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 327.64 454.27 466.47 466.59 365.29 356.13 312.37 249.65 30.24 63.19 Total Liabilities 3,307.05 3,172.06 3,021.72 2,641.80 2,418.81 2,156.42 1,949.89 1,867.80 1,258.57 1,139.56 Net Block 676.39 694.93 700.97 685.02 669.77 678.47 669.75 674.50 670.89 381.37 Gross Block 985.51 971.79 942.26 890.57 840.73 813.68 772.29 742.10 704.26 613.76 Accumulated Depreciation 309.12 276.86 241.29 205.56 170.96 135.21 102.53 67.61 33.36 232.39 Non Current Assets 1,947.92 1,730.32 1,615.15 1,299.40 1,177.74 1,109.97 973.09 954.70 738.52 640.95 Capital Work in Progress 260.88 197.84 104.36 19.21 23.85 12.38 12.84 6.32 19.92 28.80 Non Current Investment 399.70 348.71 384.95 265.58 162.53 179.33 74.40 54.82 39.76 223.12 Long Term Loans & Adv. 609.50 487.39 424.04 326.63 320.83 239.08 215.28 218.46 7.70 6.76 Other Non Current Assets 1.45 1.45 0.84 2.96 0.75 0.71 0.81 0.60 0.25 0.90 Current Assets 1,355.13 1,439.89 1,406.56 1,342.39 1,241.06 1,046.45 976.80 913.10 520.05 498.17 Current Investments 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 272.49 Inventories 383.47 323.34 303.63 213.27 209.49 172.73 159.65 136.22 130.24 121.53 Sundry Debtors 114.61 121.25 79.71 107.80 124.19 83.52 76.71 77.46 64.03 60.70 Cash & Bank 21.65 20.80 32.06 26.86 28.96 15.70 21.12 23.02 13.50 11.66 Other Current Assets 385.38 12.26 11.46 19.54 376.17 368.57 322.16 239.86 26.88 31.79 Short Term Loans & Adv. 365.27 504.94 478.94 450.07 349.81 357.56 311.65 230.44 20.30 16.15 Net Current Assets 742.91 711.22 717.96 722.33 678.69 552.24 500.72 525.69 357.93 312.44 Total Assets 3,303.05 3,170.21 3,021.71 2,641.79 2,418.80 2,156.42 1,949.89 1,867.80 1,258.57 1,139.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,097.17 1,982.05 1,956.79 1,734.13 1,547.43 1,445.24 1,276.11 1,270.20 1,082.47 936.38 Share Capital 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 17.86 Total Reserves 2,080.89 1,965.46 1,939.91 1,717.25 1,530.33 1,427.72 1,258.59 1,252.34 1,064.61 918.52 Non-Current Liabilities 604.16 468.64 391.17 299.63 314.62 229.17 211.41 216.67 19.93 24.06 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.25 0.56 0.65 0.72 0.34 0.49 0.60 0.69 0.79 0.90 Long Term Provisions 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 0.56 Current Liabilities 615.18 729.56 690.40 621.79 564.62 497.43 480.07 389.40 163.42 187.97 Trade Payables 186.03 178.49 136.94 77.28 117.86 77.61 97.32 75.10 82.59 87.17 Other Current Liabilities 101.50 96.59 86.44 77.36 80.06 61.67 68.78 64.11 50.16 36.61 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 Short Term Provisions 327.64 454.48 467.01 467.15 366.69 358.15 313.97 250.19 30.67 63.19 Total Liabilities 3,316.51 3,179.61 3,037.93 2,655.38 2,426.67 2,171.84 1,967.59 1,876.27 1,265.82 1,148.41 Net Block 680.26 698.92 705.06 689.15 673.50 682.19 673.64 678.05 675.16 393.04 Gross Block 987.18 973.27 949.42 897.55 844.97 817.80 776.49 745.84 708.81 629.67 Accumulated Depreciation 306.92 274.35 244.36 208.40 171.47 135.61 102.84 67.79 33.65 236.62 Non Current Assets 1,945.46 1,734.70 1,619.50 1,303.33 1,181.25 1,113.46 976.64 957.93 742.46 646.27 Capital Work in Progress 261.48 198.44 104.82 19.21 23.85 12.38 12.84 6.32 19.92 28.80 Non Current Investment 392.76 348.49 384.73 265.36 162.31 179.11 74.07 54.49 39.43 216.72 Long Term Loans & Adv. 609.51 487.41 424.05 326.65 320.83 239.08 215.28 218.46 7.70 6.37 Other Non Current Assets 1.45 1.45 0.84 2.96 0.75 0.71 0.81 0.60 0.25 1.33 Current Assets 1,367.05 1,443.06 1,418.43 1,352.05 1,245.41 1,058.38 990.94 918.34 523.36 502.13 Current Investments 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 272.49 Inventories 388.89 328.54 304.70 214.92 209.96 173.79 160.49 137.16 130.91 123.22 Sundry Debtors 117.38 122.65 82.17 110.54 123.74 87.53 81.66 76.06 61.94 61.04 Cash & Bank 26.29 24.94 38.66 31.58 32.32 21.26 29.30 28.47 18.02 14.95 Other Current Assets 384.46 9.94 11.70 19.76 377.15 369.88 322.33 240.12 27.10 30.44 Short Term Loans & Adv. 365.27 499.69 480.43 450.41 350.34 358.56 311.65 230.44 20.36 14.77 Net Current Assets 751.87 713.50 728.03 730.26 680.79 560.94 510.87 528.94 359.94 314.16 Total Assets 3,312.51 3,177.76 3,037.93 2,655.38 2,426.66 2,171.84 1,967.58 1,876.27 1,265.82 1,148.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 220.81 164.72 162.38 209.84 239.04 103.79 147.76 153.09 171.09 126.56 PBT 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 200.85 Adjustment -52.32 1.00 -23.59 -40.75 8.36 -13.54 -1.86 -11.07 0.24 -1.54 Changes in Working Capital -21.91 -25.11 -21.17 -36.05 -11.00 -51.34 -16.54 -18.76 -5.75 -10.77 Cash after chg. in Working capital 323.71 241.58 240.69 303.65 322.82 175.38 215.50 225.84 226.42 188.54 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -102.90 -76.86 -78.31 -93.81 -83.78 -71.60 -67.75 -69.78 -55.33 -61.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 0.00 Cash From Investing Activity -17.76 3.62 -147.42 -84.18 -84.80 -109.30 20.15 -143.55 -72.76 -88.89 Net Fixed Assets -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 Net Investments -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 -72.39 Others 102.73 46.91 84.72 86.67 33.23 45.33 37.07 46.87 -161.58 153.39 Cash from Financing Activity -202.03 -179.83 -9.70 -126.49 -142.00 -0.07 -169.43 0.35 -96.98 -47.47 Net Cash Inflow / Outflow 1.02 -11.48 5.26 -0.83 12.24 -5.58 -1.53 9.90 1.36 -9.80 Opening Cash & Equivalents 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74 10.58 21.08 Closing Cash & Equivalent 20.77 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74 11.28

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 220.77 154.91 161.65 207.08 250.38 112.43 149.84 154.49 174.30 127.64 PBT 396.22 257.80 289.39 389.85 319.95 237.75 240.63 257.71 232.15 203.65 Adjustment -51.18 4.32 -26.48 -48.34 22.58 -0.21 0.39 -10.88 2.41 -1.40 Changes in Working Capital -20.35 -29.91 -21.72 -39.42 -7.77 -51.05 -23.24 -19.23 -4.54 -11.78 Cash after chg. in Working capital 324.69 232.21 241.19 302.09 334.77 186.49 217.78 227.60 230.02 190.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -103.92 -77.30 -79.54 -95.01 -84.39 -74.06 -67.94 -70.14 -55.73 -62.84 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 0.00 Cash From Investing Activity -17.08 11.13 -144.57 -77.15 -98.35 -120.33 20.11 -143.55 -73.05 -88.57 Net Fixed Assets -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 Net Investments -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 -72.39 Others 103.41 54.42 87.57 93.70 19.68 34.30 37.03 46.87 -161.87 153.71 Cash from Financing Activity -202.16 -179.95 -9.84 -129.35 -142.00 -0.07 -169.43 0.35 -96.98 -47.76 Net Cash Inflow / Outflow 1.53 -13.90 7.25 0.58 10.03 -7.96 0.52 11.29 4.27 -8.69 Opening Cash & Equivalents 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25 12.17 23.26 Closing Cash & Equivalent 25.42 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25 14.56

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 128.81 119.39 115.44 102.02 90.18 82.16 72.38 71.06 60.53 52.22 ROA 9.48% 6.49% 7.76% 11.64% 10.79% 8.35% 8.82% 11.97% 14.09% 13.24% ROE 15.06% 10.23% 11.97% 18.04% 16.59% 12.73% 13.33% 15.99% 16.85% 16.50% ROCE 19.71% 13.70% 15.66% 23.43% 22.06% 17.63% 18.62% 21.45% 23.25% 22.89% Fixed Asset Turnover 2.02 1.91 1.71 1.57 1.65 1.39 1.41 1.45 1.53 1.68 Receivable days 21.82 20.01 21.87 31.18 27.76 26.53 26.29 24.69 22.54 24.73 Inventory Days 65.39 62.44 60.30 56.83 51.08 55.04 50.45 46.49 45.50 45.20 Payable days 102.61 87.79 73.61 86.01 38.13 40.20 41.31 40.79 44.71 48.03 Cash Conversion Cycle -15.40 -5.34 8.56 2.00 40.71 41.37 35.43 30.39 23.32 21.90 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 100.49 66.79 94.65 112.82 96.31 166.02 167.77 178.52 167.05 115.57

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 128.81 119.47 115.92 102.73 90.51 82.86 73.17 71.42 60.87 52.62 ROA 9.39% 6.23% 7.59% 11.85% 10.48% 8.30% 9.05% 12.00% 14.01% 13.34% ROE 14.96% 9.84% 11.71% 18.36% 16.10% 12.63% 13.67% 16.02% 16.76% 16.64% ROCE 19.62% 13.27% 15.78% 23.74% 21.63% 17.64% 19.04% 21.51% 23.15% 23.02% Fixed Asset Turnover 2.04 1.91 1.70 1.57 1.66 1.41 1.42 1.44 1.52 1.65 Receivable days 21.91 20.32 22.35 31.31 27.96 27.55 26.58 23.96 22.06 24.19 Inventory Days 65.48 62.83 60.27 56.79 50.80 54.43 50.15 46.55 45.58 45.45 Payable days 101.39 87.78 73.73 86.01 38.19 40.35 41.32 40.83 44.81 47.89 Cash Conversion Cycle -14.00 -4.62 8.89 2.09 40.57 41.62 35.41 29.68 22.84 21.74 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 99.22 64.07 94.67 113.90 94.95 166.95 172.62 179.60 167.11 113.30

Top Investors:

icici prudential smallcap fund

nippon life india trustee ltd-a/c nippon india small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

FDC recalling 60,428 bottles of Timolol Maleate Ophthalmic Solution in US market
12th May 2025, 12:44 PM

The drugmaker initiated the Class II nationwide (US) recall on April 18, 2025
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback